TUESDAY, Aug. 12 (HealthDay News) -- The latest update from a European study that has followed men with prostate cancer for more than a decade leaves the debate about the advantages of aggressive treatment versus "watchful waiting" undecided.

The advantage in survival seen for men who underwent surgery to remove the prostate disappeared after 10 years. While deaths attributed to cancer continued to be lower among those having surgery, the overall death rate for both groups was the same, according to the researchers with the Scandinavian Prostate Cancer Group.

MONDAY, Aug. 11 (HealthDay News) -- One in five men in their 40s has had a prostate-specific antigen (PSA) test in the past year, and young black men are more likely than young white men to have undergone the test, a new analysis shows.

The findings, published in the Sept. 15 issue of Cancer, should help experts as they reassess prostate cancer screening recommendations.

By Ed Edelson
EmpowHer's HealthDay Reporter

MONDAY, March 10 (HealthDay News) -- Changes in medical practice have undermined the value of the prostate-specific antigen (PSA) test as a diagnostic tool for prostate cancer, a new study asserts.

However, that assertion was immediately challenged by other experts in the field.

The American Cancer Society recommends annual screening for prostate cancer for most men after age 50. The screening is done in two steps: a digital rectal exam, followed by a blood test for PSA, a protein produced by the prostate gland.

Gwyneth Paltrow has filmed a public service announcement for UNICEF to help raise money to prevent children being born with the HIV virus.

Paltrow's video clip was launched online Wednesday.

Read more